Log in

Start Your Membership Now

October 12, 2010 On October 12, 2010, the U.S. Food and Drug Administration (FDA) sent a warning letter to Hormonal Health, LLC, for marketing non-prescription “chelation” products as treatments for a range of disorders including autism. The FDA warning to the public noted that the companies’ claims of health benefits for specific conditions have not been proven. No chelation agents have been approved for any use without a prescription. The products have been marketed as “dietary supplements” in a variety of dosages and forms, including suppositories, capsules, liquid drops, sprays and clay baths. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Market Intelligence Resources